RNAZ

Transcode Therapeutics Inc

1.860

+0.150+8.77%

After Hours: 1.830 -0.030 -1.61%19:30 10/09 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.780/1.710

TODAY RANGE1.740-1.950

VOL84.08K

MARKET CAP31.49M

52 WEEK RANGE1.520-20.99

AVG VOL (3M)50.97K

% TURNOVER0.48%

TURNOVER--

P/E (TTM)-0.0366

% RANGE12.28%

EPS(TTM)-50.7606

P/E(FORWARD)-4.2761

P/B0.0136

BVPS136.77

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP30.93M

SHARES OUTSTANDING16.93M

NEXT EARNINGS--

FREE FLOAT16.63M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·10/01 20:33
TransCode Therapeutics Eases Near-Term Obligations Under Financing
TipRanks·09/28 13:02
TransCode Highlights Promising Phase 1a Results for TTX-MC138
Benzinga·09/28 12:11
TransCode Therapeutics Announces Updated Clinical Data From Phase 1a Clinical Trial Of TTX-MC138, Reinforcing Evidence Of Antitumor Activity In Heavily Pretreated Patients With Advanced Solid Tumors
TipRanks·09/28 12:10
Transcode Therapeutics reports updated results from Phase 1a TTX-MC138 trial
Benzinga·09/22 12:10
TransCode Therapeutics Announces Australia Acceptance Of Patent application, Japan's Issuance Of Notice Of Allowance For Its RNA-Based Therapeutic Platform Technologies
TipRanks·09/11 21:26
TransCode Therapeutics Announces CFO Resignation and Interim Appointment
Dow Jones·09/10 21:36
TransCode Therapeutics Taps Tattory to Be Interim CFO
Seeking Alpha·09/10 20:23
TransCode Therapeutics CFO retires
Benzinga·09/10 20:22
TransCode Therapeutics, CFO Tom Fitzgerald Plans To Retire; John Tattory To Serve As Interim Finance Chief, Effective Immediately
TipRanks·09/10 20:20
Transcode Therapeutics CFO Fitzgerald retiring, Tattory named interim CFO
Dow Jones·09/10 20:17
*Transcode Therapeutics: Fitzgerald Will Continue to Provide Transition Services >RNAZ
Dow Jones·09/10 20:16
*Transcode Therapeutics: John Tattory to Become Interim Chief Fincl Officer >RNAZ
Dow Jones·09/10 20:16
*Transcode Therapeutics: Tom Fitzgerald, Chief Fincl Officer, to Retire
Dow Jones·09/10 20:16
*Transcode Therapeutics: Fitzgerald Will Resign as CFO and as a Director, Effective Immediately >RNAZ
Dow Jones·09/10 20:10
Press Release: TransCode Therapeutics Announces Leadership Transition

Same Industry

Name/Symbol

Change%

Price

RNAZ

REGN

GRDX

BNTX

United Therapeutics Corp.

UTHR

+3.07%

549.16

VRTX

SIGA

Moderna

MRNA

+14.21%

225.00

CRL

MEDP

TLPH

ICLR

CBPO

IQV

MOLN

Arcturus Therape

ARCT

+6.76%

13.74

GILD

PRAH

INCY

APVO

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.